Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More

Purigen Biosystems Ionic FFPE Complete Purification Kit

Purigen Biosystems has launched the Ionic FFPE Complete Purification Kit, which enables users to consistently recover both DNA and RNA simultaneously from formalin-fixed, paraffin-embedded tissue samples in a single workflow. Purigen said that the workflow reduces hands-on time by as much as 75 percent compared to manual column or bead-based methods. The kit uses the company's Ionic Purification System, a benchtop instrument that uses isotachophoresis and so-called Ionic Fluidic Chips to automate the extraction of nucleic acids from a wide range of sample types. The Ionic FFPE Complete Purification Kit consists of 12 chips and a reagent set with all necessary enzymes and buffers to perform DNA extraction from 48 samples.

Zymo Research Environ COVID-19 Wastewater Testing Service

Zymo Research has launched the Environ COVID-19 Wastewater Testing Service to facilitate daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. The service uses an RT-qPCR assay that targets the N1 gene specific to SARS-CoV-2, and quantification is based on a standard curve of in vitro SARS-CoV-2 RNA diluted down from 5,000 copies to 8 copies per reaction, the company notes on its website. Participants are provided with sample collection devices, for daily wastewater submission, and materials for secure, pre-paid overnight shipping. Within 24 hours of sample submission, users receive an electronic report containing case estimates, daily concentration trends, and the detection of variant strains of concern.

Qiagen QiaSphere for QiaStat-Dx

Qiagen has launched its QiaSphere cloud-based platform that will allow labs and users of the company's QiaStat-Dx syndromic molecular testing platform to continually monitor tests and instrument status. The platform can monitor a nearly unlimited number of instruments, providing visibility of testing routines across different hospitals or satellite labs. Customers will be able to receive instrument and test status push notifications across their personal devices, and continuous connectivity will allow Qiagen technical service to monitor instrument health in real time, the company said. Qiagen began marketing and distributing QiaSphere for the QiaCube Connect platform in early 2021.

For more new products and services, please visit the New Products page on our website.